{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:35:15Z","timestamp":1775093715128,"version":"3.50.1"},"reference-count":57,"publisher":"The Journal of Rheumatology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To identify the instruments used to assess polymyalgia rheumatica (PMR) in published studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A systematic literature review of clinical trials and longitudinal observational studies related to PMR, published from 1970 to 2014, was carried out. All outcome and assessment instruments were extracted and categorized according to core areas and domains, as defined by the OMERACT (Outcome Measures in Rheumatology) Filter 2.0.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Thirty-five articles (3221 patients) were included: 12 randomized controlled trials (RCT); 3 nonrandomized trials; and 20 observational studies. More than 20 domains were identified, measured by 29 different instruments. The most frequently used measures were pain, morning stiffness, patient global assessment and physician global assessment, erythrocyte sedimentation rate, and C-reactive protein. The definition of outcomes varied considerably between studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The outcome measures and instruments used in PMR are numerous and diversely defined. The establishment of a core set of validated and standardized outcome measurements is needed.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.150515","type":"journal-article","created":{"date-parts":[[2015,11,15]],"date-time":"2015-11-15T20:07:47Z","timestamp":1447618067000},"page":"2503-2511","source":"Crossref","is-referenced-by-count":15,"title":["Outcome Measures in Polymyalgia Rheumatica. A Systematic Review"],"prefix":"10.3899","volume":"42","author":[{"given":"C\u00e1tia","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Jorge de Oliveira","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Louise","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Richard","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ant\u00f3nio","family":"Pereira da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The OMERACT Polymyalgia Rheumatica Special Interest Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2015,11,15]]},"reference":[{"key":"2018112909350707000_42.12.2503.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30155"},{"key":"2018112909350707000_42.12.2503.2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.072157"},{"key":"2018112909350707000_42.12.2503.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.22630"},{"key":"2018112909350707000_42.12.2503.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2002.002618"},{"key":"2018112909350707000_42.12.2503.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133850"},{"key":"2018112909350707000_42.12.2503.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011379"},{"key":"2018112909350707000_42.12.2503.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131306"},{"key":"2018112909350707000_42.12.2503.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131309"},{"key":"2018112909350707000_42.12.2503.9","unstructured":"Boers M Kirwan JR Tugwell P Beaton D Bingham CO 3rd Conaghan PG The OMERACT handbook. [Internet. Accessed March 3, 2015.] Available from: www.omeract.org\/pdf\/OMERACT_Handbook.pdf"},{"key":"2018112909350707000_42.12.2503.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.013"},{"key":"2018112909350707000_42.12.2503.11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131314"},{"key":"2018112909350707000_42.12.2503.12","doi-asserted-by":"publisher","DOI":"10.1007\/BF02556669"},{"key":"2018112909350707000_42.12.2503.13","first-page":"1097","article-title":"Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study","volume":"22","author":"Littman","year":"1995","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.14","first-page":"1660","article-title":"A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica","volume":"22","author":"Krogsgaard","year":"1995","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.15","first-page":"1492","article-title":"Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens","volume":"22","author":"Di Munno","year":"1995","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.2.143"},{"key":"2018112909350707000_42.12.2503.17","first-page":"624","article-title":"Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study","volume":"23","author":"Ferraccioli","year":"1996","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.2.189"},{"key":"2018112909350707000_42.12.2503.19","first-page":"1470","article-title":"Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study","volume":"27","author":"Salvarani","year":"2000","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-7-200410050-00005"},{"key":"2018112909350707000_42.12.2503.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00005"},{"key":"2018112909350707000_42.12.2503.22","doi-asserted-by":"publisher","DOI":"10.1186\/ar3140"},{"key":"2018112909350707000_42.12.2503.23","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-010-0276-6"},{"key":"2018112909350707000_42.12.2503.24","first-page":"760","article-title":"Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study","volume":"30","author":"Salvarani","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.23095"},{"key":"2018112909350707000_42.12.2503.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-94"},{"key":"2018112909350707000_42.12.2503.27","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.6.577"},{"key":"2018112909350707000_42.12.2503.28","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2000.8366"},{"key":"2018112909350707000_42.12.2503.29","doi-asserted-by":"publisher","DOI":"10.1080\/03009740310000382"},{"key":"2018112909350707000_42.12.2503.30","doi-asserted-by":"publisher","DOI":"10.1002\/art.20901"},{"key":"2018112909350707000_42.12.2503.31","first-page":"703","article-title":"Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse\/recurrence in polymyalgia rheumatica","volume":"33","author":"Boiardi","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.22548"},{"key":"2018112909350707000_42.12.2503.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.22771"},{"key":"2018112909350707000_42.12.2503.34","doi-asserted-by":"publisher","DOI":"10.1002\/art.22777"},{"key":"2018112909350707000_42.12.2503.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.23338"},{"key":"2018112909350707000_42.12.2503.36","first-page":"395","article-title":"Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids","volume":"26","author":"Cimmino","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909350707000_42.12.2503.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.23924"},{"key":"2018112909350707000_42.12.2503.38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep286"},{"key":"2018112909350707000_42.12.2503.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1399-0"},{"key":"2018112909350707000_42.12.2503.40","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113555"},{"key":"2018112909350707000_42.12.2503.41","doi-asserted-by":"publisher","DOI":"10.1159\/000332031"},{"key":"2018112909350707000_42.12.2503.42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110851"},{"key":"2018112909350707000_42.12.2503.43","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110866"},{"key":"2018112909350707000_42.12.2503.44","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110977"},{"key":"2018112909350707000_42.12.2503.45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes294"},{"key":"2018112909350707000_42.12.2503.46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131055"},{"key":"2018112909350707000_42.12.2503.47","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-5-672"},{"key":"2018112909350707000_42.12.2503.48","doi-asserted-by":"publisher","DOI":"10.1136\/ard.38.5.434"},{"key":"2018112909350707000_42.12.2503.49","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(84)90012-X"},{"key":"2018112909350707000_42.12.2503.50","doi-asserted-by":"publisher","DOI":"10.1136\/ard.40.1.1"},{"key":"2018112909350707000_42.12.2503.51","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6"},{"key":"2018112909350707000_42.12.2503.52","doi-asserted-by":"publisher","DOI":"10.1136\/jech.53.1.46"},{"key":"2018112909350707000_42.12.2503.53","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088526"},{"key":"2018112909350707000_42.12.2503.54","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131254"},{"key":"2018112909350707000_42.12.2503.55","first-page":"1031","article-title":"Concordance between clinician and patient assessment of physical and mental health status","volume":"19","author":"Kwoh","year":"1992","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.56","first-page":"675","article-title":"Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity","volume":"27","author":"Neville","year":"2000","journal-title":"J Rheumatol"},{"key":"2018112909350707000_42.12.2503.57","first-page":"818","article-title":"Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia","volume":"21","author":"Hidding","year":"1994","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.150515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T14:02:46Z","timestamp":1543500166000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.150515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,15]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,1]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.3899\/jrheum.150515"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.150515","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,15]]}}}